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Abstract
The aristaless-related homeobox (ARX) transcription factor is involved in the development of GABAergic and cholinergic neu-
rons in the forebrain. ARX mutations have been associated with a wide spectrum of neurodevelopmental disorders in
humans, among which the most frequent, a 24 bp duplication in the polyalanine tract 2 (c.428_451dup24), gives rise to intellec-
tual disability, fine motor defects with or without epilepsy. To understand the functional consequences of this mutation, we
generated a partially humanized mouse model carrying the c.428_451dup24 duplication (Arxdup24/0) that we characterized at
the behavior, neurological and molecular level. Arxdup24/0 males presented with hyperactivity, enhanced stereotypies and
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altered contextual fear memory. In addition, Arxdup24/0 males had fine motor defects with alteration of reaching and grasping
abilities. Transcriptome analysis of Arxdup24/0 forebrains at E15.5 showed a down-regulation of genes specific to interneurons
and an up-regulation of genes normally not expressed in this cell type, suggesting abnormal interneuron development.
Accordingly, interneuron migration was altered in the cortex and striatum between E15.5 and P0 with consequences in
adults, illustrated by the defect in the inhibitory/excitatory balance in Arxdup24/0 basolateral amygdala. Altogether, we showed
that the c.428_451dup24 mutation disrupts Arx function with a direct consequence on interneuron development, leading to
hyperactivity and defects in precise motor movement control and associative memory. Interestingly, we highlighted striking
similarities between the mouse phenotype and a cohort of 33 male patients with ARX c.428_451dup24, suggesting that this
new mutant mouse line is a good model for understanding the pathophysiology and evaluation of treatment.
Introduction
So far, more than 100 mutations have been identified in human
in the aristaless-related homeobox (ARX) transcription factor
encoding gene, located on the X chromosome. Depending on
the phenotypic severity, ARX mutations can be divided into two
groups: (i) a group with brain malformations, including X-linked
lissencephaly with abnormal genitalia (1–3), hydranencephaly
with abnormal genitalia and Proud syndrome (4), and (ii) a
group without brain malformation, comprising X-linked intel-
lectual disability (ID) with or without epilepsy and Partington
syndrome (ID and dystonic movements of the hands) (see for
reviews 5–7).
ARX is involved in GABAergic neuron development in the
cortex, hippocampus and basal ganglia, and in cholinergic neu-
ron development in the striatum, medial septum and ventral
forebrain nuclei (2,5,8,9). Accordingly, its expression is con-
trolled by Dlx transcription factors (10,11), which are important
for the differentiation of telencephalic GABAergic neurons (12)
and it regulates the expression of several genes important
for brain development, in particular interneuron development
(13–16).
ARX protein contains a homeodomain implicated in DNA
binding, an aristaless domain at the C-terminus, responsible for
transcriptional activation, an octapeptide domain close to the
N-terminus, involved in transcriptional repression, and four
polyalanine tracts whose function is not well known (17).
Interestingly, the majority of ARX mutations affects the two first
polyalanine tracts of ARX protein. In particular, the in-frame
24 bp duplication (c.428_451dup24), that expands the normal 12
polyalanine tract 2 to 20 (aa 144–155), occurs in 67–76% of unre-
lated ARX mutated patients without brain malformation (7,18).
Originally, the c.428_451dup24 mutation was reported to cause
variable phenotypes, including West syndrome, Partington syn-
drome and non-syndromic X-linked ID. However, recent clinical
re-evaluation of c.428_451dup24 patients suggested that this
mutation constitutes a recognizable clinical syndrome with ID,
an oro-lingual apraxia and a very specific upper limb distal mo-
tor apraxia associated with a pathognomonic handgrip and var-
iable epilepsy expression (19).
So far, the effect of ARX polyalanine expansions is not well
understood. Overexpression experiments have suggested that
they may cause protein aggregation and subsequent increased
cell death in transfected cells (5,20,21) although two studies in
transgenic mice for two different expansions in ARX polyala-
nine tracts [c.304ins(GCG)7 and c.428_451dup24] have reported
the absence of detectable protein aggregates or cell death in vivo
(22,23). More recently, ARX polyalanine expansions have been
shown to spontaneously promote the inappropriate self-
assembly of these sequences into a-helical clusters with diverse
oligomeric states, likely leading to the disruption of normal pro-
tein interactions (24). It has also been suggested that
polyalanine expansions may affect directly ARX transcription
activity. ARX can act both as a transcriptional repressor and ac-
tivator (17,25). In vitro studies suggested that polyalanine expan-
sions result in an increased repression activity (17). In contrast,
studies in transfected cells showed less or decreased repression
of some ARX known target genes with c.304ins(GCG)7 and
c.428_451dup24, suggesting a partial loss-of-function effect
(6,26,27). Nevertheless, it is more likely that these polyalanine
expansions result in the misregulation of a subset of target
genes, as shown for c.304ins(GCG)7 mutation in mice (26).
To better understand the in vivo effect of polyalanine expan-
sions on ARX functions, two mouse models for the
c.304ins(GCG)7 mutation have been generated (22,23) and their
phenotypes were very similar to human patients. So far, only
one model has been generated for the c.428_451dup24 (called
dup24) mutation and was reported to have no major phenotype
(23), although some of ARX target genes were found misregu-
lated in these mice (27). Unlike the previous dup24 mouse
model which was created by the insertion of 24 bp expansion in
the polyalanine tract 2 of the mouse Arx gene (23), we here gen-
erated and characterized a new partially humanized knock-in
mouse line carrying part of human ARX exon 2 coding for the
polyalanine tract 1 and the expanded polyalanine tract 2.
Results
Decreased Arx mRNA and protein expression in
Arxdup24/0 mutant brains
The Arxdup24/0 mutant mouse line was generated as described in
Figure 1A and B and the Supplementary Material. Interestingly,
we found that the polyalanine tract 2 containing the duplication
of 24 bp is rather unstable at the DNA level and can result in
mosaicism in a small fraction of cells (see Supplementary
Material, Fig. S1).
Brains from Arxdup24/0 males looked normal in size and did
not show any gross malformation at E15.5, P0 and in adult
(Supplementary Material, Fig. S2A–F). However, when we looked
at ARX expression at E15.5 by immunohistochemistry, we no-
ticed that ARXþ cells were generally less strongly labeled in the
brain of Arxdup24/0 than Arxwt/0 mice (Supplementary Material,
Fig. S2G and H), suggesting a reduction of the amount of ARX
protein. To confirm this observation, we quantified Arx mRNA
and protein in Arxdup24/0 and Arxwt/0 E15.5 forebrains. We ob-
served a slight but significant reduction of Arx mRNA in
Arxdup24/0 mice (Fig. 1C) and a 23% reduction of ARX protein in
Arxdup24/0 mice (Fig. 1D and E), which is consistent with 8–50%
decreased protein amount reported in another mouse model for
the same mutation (27). We also quantified Arx expression in
adult brain, and found a similar decrease at the mRNA level
which however did not reach statistical significance (ratio Arx
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Ar t/0 Ar p24/0
GAC GGC GCA GGG GCC GCC  GCG GCA GCC  GCG GCC GCG GCC  GCC  GCG GCA GCC  GCG GCC  GCG GCC  GCC GCG GCC TGG 
CTG  CCG CGT  CCC  CGG CGG CGC CGT  CGG CGC  CGG CGC CGG CGG CGC  CGT  CGG CGC  CGG CGC  CGG CGG CGC CGG ACC 
Figure 1. Generation of Arx knock-in mouse line (Arxdup24/0). (A) A targeting vector containing a partially humanized mouse exon 2 fragment (corresponding to human
ARX amino-acid 79–160) carrying the human c.428_451dup24 mutation was generated and electroporated into male 129sv pass ES cells to obtain the targeted allele. The
floxed Neo selection cassette was removed in vivo by direct breeding of the chimaeras with a CMV-Cre deleter line. The Cre transgene was segregated by a further
breeding step. (B) Detection of wild-type (wt) and mutated alleles by RT-PCR in four different adult brain regions (cortex, olfactory bulb, striatum and amygdala) from
one Arxwt/0 and two Arxdup24/0 males, respectively. Note that we observed a band below the band corresponding to the mutated allele which was probably the result of
the instability of the polyalanine tract 2 with the 24 bp duplication (see Supplementary Material). (C) Graph showing the expression levels of Arx mRNA in four Arxwt/0
and four Arxdup24/0 E15.5 males normalized to the mean expression level in Arxwt/0 males. A significant reduction of Arx mRNA expression was observed by qRT-PCR in
Arxdup24/0 E15.5 forebrain (Arxwt/0: 1.0160.01, n¼4 versus Arxdup24/0: 0.8860.06, n¼4, P¼0.029, unpaired t-test). (D) Western blot showing Arx expression in three Arxdup24/0
and three Arxwt/0 E15.5 mouse forebrains. Semi-quantification was performed on Arx specific band, corresponding to the lower band (shown by the arrow) and which is
absent in the negative control. N2a cells transfected with Arx cDNA or FLAG cDNA were used as positive and negative controls, respectively. Note that we detected a
shift in the size of Arx protein (due to the presence of the 24 bp duplication) in the three Arxdup24/0 mice when compared to the three Arxwt/0 mice. (E) Graph showing
the quantification of Arx protein expression in western blot normalized to Arx protein expression in Arxwt/0 males. A significant reduction of Arx protein expression
in Arxdup24/0 E15.5 forebrain was observed by protein dosage on the western blot (Arxwt/0: 1.0060.12, n¼3 versus Arxdup24/0: 0.766 0.07, n¼3, P¼0.040, unpaired t-test). Ctx:
cortex, OB: olfactory bulb, St: striatum, Am: amygdala.
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mRNA in Arxdup24/0 versus Arxwt/0: 0.88 6 0.15, n ¼ 4, P ¼ 0.47, un-
paired t-test). Unfortunately, the level of ARX protein was too
low in adult to allow a precise quantification by western blot.
Eight percent of Arxdup24/0 pups presented with infantile
spams, but no increased susceptibility to induced
epilepsy in adult
As infantile spasms were occasionally described in ARX
c.428_451dup24 patients (28), we tested Arxdup24/0 males for the
presence of infantile spontaneous motor spasms at P7, P9 and
P11 during 30 min by video-monitoring. None of the 34 Arxwt/0
pups displayed any spontaneous motor spasms, whereas two of
the 25 Arxdup24/0 pups (corresponding to 8% of Arxdup24/0 pups)
showed spasms (Fig. 2A and B). In addition, we tested the sus-
ceptibility of adult Arxdup24/0 males to seizures induced by injec-
tion of a pro-convulsive agent, the pentylenetetrazole (PTZ).
When a dose of 50 mg/kg of PTZ was administered intraperito-
neally to mice, no difference in susceptibility to seizures was
observed between Arxwt/0 and Arxdup24/0 mice. Myoclonic, clonic
and tonic seizures frequencies (clonic: v2 ¼ 0.029, P ¼ 0.864;
tonic: v2 ¼ 1.485, P ¼ 0.223; death: v2 ¼ 1.485, P ¼ 0.223, Chi
square test), as well as the latency of clonico-tonic seizure (clo-
nico-tonic latency: t19 ¼ 0.046, P ¼ 0.964, Student t-test) were
comparable between genotypes (Fig. 2C and D), suggesting that
adult Arxdup24/0 males do not have increased susceptibility to
seizures.
Arxdup24/0 males show hyperactivity and alteration of
contextual fear conditioning
ARX c.428_451dup24 patients present a variety of neurological
and behavioral manifestations (19; this study), thus we investi-
gated our mouse model for those manifestations. Arxdup24/0
males had normal physical appearance and body weight and
did not show any obvious sign of altered sensory or vestibular
functions. The locomotor activity was increased in Arxdup24/0 as
compared to Arxwt/0 males in several tests as shown by the
higher: (i) distance travelled in the open field arena {[F(1,
20) ¼ 5.92, P ¼ 0.025, repeated measures ANOVA]; P < 0.05 for 10,
15 and 20 min time points with Student t-test} (Fig. 3A), (ii) num-
ber of visited arms in the Y maze (t20 ¼ 3.69, P ¼ 0.0015, Student
t-test) (Fig. 3B) and (iii) total number of entries in the chambers
in the social recognition test (t20 ¼ 1.75, P ¼ 0.095, Student t-test)
(Supplementary Material, Fig. S3A). Arxdup24/0 mutants also
showed increased vertical activity (rearing) in the open field
{[F(1, 20) ¼ 9.41, P ¼ 0.006, repeated measures ANOVA]; P < 0.05
for 10–30 min time points with Student t-test} (Fig. 3A) and
throughout the testing period of the circadian activity
(t20 ¼ 1.99, P ¼ 0.061, Student t-test) (Fig. 3C). Altogether, we
found that Arxdup24/0 males displayed hyperactivity and en-
hanced stereotypy (illustrated by rearing activity), particularly
in new environments.
We then performed different assays to assess social and
emotional behavior and learning and memory abilities of
Arxdup24/0 mutants (see Supplementary Material, Fig. S3). In the
Figure 2. Eight percent of Arxdup24/0 pups present with infantile spasms, however adult Arxdup24/0 mice have comparable seizure susceptibility than Arxwt/0 mice after
PTZ injection. (A) Still frames selected from a digital video recording of two Arxwt/0 and one Arxdup24/0 pups depicting an Arxdup24/0 pup of 9 days old (bottom row) having
motor spasms during more than 20 sec involving sustained flexion of all limbs (left panel). (B) Major spasms were observed in 2 out of 25 Arxdup24/0 pups, but were never
observed in any of the 34 Arxwt/0 pups. (C and D) Quantification of the seizures susceptibility in Arxwt/0 and Arxdup24/0 mice after injection of 50 mg/kg of pentylenetetra-
zol (PTZ). (C) The percentage of animals showing myoclonic, clonic or tonic seizures was similar between Arxdup24/0 and Arxwt/0 mice. (D) The latency of seizure appear-
ance was also comparable between the two genotypes.











egen user on 03 June 2021
fear conditioning test, Arxdup24/0 mutants exposed to the condi-
tioning cage tended to have lower baseline levels of immobility
than Arxwt/0 mice during the habituation [F(1, 19) ¼ 3.72,
P ¼ 0.069, repeated measures ANOVA] (Fig. 3D), which could be
attributed to their hyperactivity. When animals were
re-exposed to the same context 24 h after conditioning, both
Arxwt/0 and Arxdup24/0 mice showed significantly, but differently,
increased freezing as compared to the baseline [pre–post condi-
tioning: F(1, 19) ¼ 31.97, P < 0.0001; interaction genotype*time
F(1, 19) ¼ 3.58, P ¼ 0.074; genotype: F(1, 19) ¼ 6.44, P ¼ 0.020;
repeated ANOVA on the last 2 min of habituation and the first
2 min of context] (Fig. 3D). Indeed, contextual freezing perfor-
mance was significantly lower in Arxdup24/0 mutants as compared
to Arxwt/0 counterparts {[F(1, 19)¼ 10.10, P ¼ 0.005, repeated meas-
ures ANOVA]; P < 0.05 for each time point, Student t-test}.
When animals were placed in a new context, Arxdup24/0 mutants
still had lower baseline immobility than Arxwt/0 (t19 ¼ 2.43,
P ¼ 0.025, Student t-test) (Fig. 3E). Presentation of conditional
stimuli alone in the new context induced in both genotypes a







































































































































Figure 3. Arxdup24/0 males presented with hyperactivity and alteration of contextual fear conditioning. (A–D) Hyperactivity was observed in several tests. (A) In the
open-field, the distance travelled (t20 ¼2.43, P<0.05) (upper panel) and the number of rears (lower panel) were significantly increased in Arxdup24/0 compared to Arxwt/0
mice. (B) In the Y-maze, the number of visited arms was significantly increased in mutants. (C) Arxdup24/0 males showed increased vertical activity throughout the light/
dark cycle when compared to Arxwt/0 males. (D) In the fear conditioning paradigm, when animals were re-exposed in the same context 24 h after conditioning, both
genotypes showed increased freezing compared to baseline, however contextual freezing performance was significantly decreased in Arxdup24/0 mutants. Note that
Arxdup24/0 males tended to have lower baseline levels of immobility during habituation than Arxwt/0 mice. (E) However, when animals were placed in a new
context, Arxdup24/0 mice showed same cued freezing performance than Arxwt/0. Note that Arxdup24/0 mice showed decreased baseline immobility compared to Arxwt/0
males, but not when testing for cue memory. *P<0.05, **P<0.01 versus wt.
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performance between genotypes [F(1, 19) ¼ 0.009, P ¼ 0.926, re-
peated measures ANOVA] (Fig. 3E) and excluding the possibility
that Arxdup24/0 males’ hyperactivity was responsible for the alter-
ation in the contextual memory. Altogether, these data suggest
specific alteration of contextual memory for fear in Arxdup24/0
mice.
Arxdup24/0 males show altered fine motor and
proprioceptive abilities
In order to determine if our mouse model recapitulates the
fine motor phenotypes observed in ARX c.428_451dup24
patients (19; this study), we evaluated the fine motor skills.
Beforehand, we assessed mouse muscle strength with the grip
test and their traction force in the string test and did not ob-
serve any differences between Arxdup24/0 and Arxwt/0 mice (grip
strength: t19 ¼ 1.08, P ¼ 0.294; traction force: t19 ¼ 1.06,
P > 0.05, Student t-test), suggesting normal muscle strength in
mutant mice (Supplementary Material, Fig. S3B). We then per-
formed the mouse reaching and grasping (MoRaG) test (29,30).
Both Arxwt/0 and Arxdup24/0 were highly lateralized, using either
the left or the right paw to proceed [lateralization:
F(2, 94) ¼ 15.48, P < 0.0001; interaction genotype*lateralization
F(2, 94) ¼ 2.73, P ¼ 0.071; repeated measures ANOVA on the
three sessions] (Fig. 4A). Interestingly, over the three testing
sessions, Arxdup24/0 mice showed significantly decreased accu-
racy of reaching {[F(1, 47) ¼ 7.54, P ¼ 0.009, repeated ANOVA];
P < 0.01 for day 2 and 3 Student t-test} and grasping
{[F(1, 47) ¼ 13.07, P ¼ 0.0007, repeated ANOVA, followed by
Student t-test for each day P < 0.05]; P < 0.05 for each day
Student t-test} than Arxwt/0 mice (Fig. 4A), suggesting that
Arxdup24/0 mice have altered precision in movement toward the
target and deficient fine-tuned grasping ability. In addition, we
evaluated gait of Arxdup24/0 versus Arxwt/0 mice. In the beam
walking test, Arxdup24/0 mice took as much time as Arxwt/0 mice
to cross the beam distance (t17 ¼ 1.18, P ¼ 0.254, Student t-test),
but showed significantly higher number of slips than Arxwt/0
mice (t17 ¼ 2.94, P ¼ 0.009, Student t-test) (Fig. 4B). Automated
gait analysis revealed that Arxdup24/0 mice have several fine lat-
eralized motor changes with increased: (i) right hind paw
stance duration (t14 ¼ 2.14, P ¼ 0.050, Student t-test) (Fig. 4C),
(ii) left forelimb brake duration (t14 ¼ 2.32, P ¼ 0.036, Student t-
test) (Fig. 4C) and (iii) left hind paw propel duration (t14 ¼ 2.18,
P ¼ 0.047, Student t-test) (Fig. 4C); as if the higher propulsion
was compensated by higher brake in mutants. Arxdup24/0 mice
also had increased step angle for the forepaws (t14 ¼ 3.11,
P ¼ 0.008, Student t-test) (Fig. 4C). The gait parameters were
even more affected in a second older cohort (15–31 weeks old)
where all limbs had increased stance and propel duration (t17
 2.12, P < 0.05, Student t-test; Supplementary Material, Fig.
S3H). Finally, we analyzed Arxdup24/0 mice for specific motor
coordination. Arxdup24/0 mice showed significantly higher la-
tencies to fall from the rotarod than Arxwt/0 mice (t19 ¼ 2.19,
P ¼ 0.042; Student t-test) (Supplementary Material, Fig. S3C),
suggesting improved motor coordination of Arxdup24/0 mice. It
is possible that as Arxdup24/0 mutants are more active than
Arxwt/0, they manage to better anticipate the increase in the
rotation speed, which leads to a better performance at the
rotarod than Arxwt/0 mice. Altogether, these results suggest
that Arxdup24/0 mice present alteration of fine motor and pro-
prioceptive abilities without major impact on coordination.
Down-regulation of interneuron specific genes in
Arxdup24/0 forebrain at E15.5
To gain better insights into the molecular consequences associ-
ated with the 24 bp duplication, we performed genome-wide
RNA sequencing (RNA-seq) on embryonic E15.5 forebrains from
Arxdup24/0 and Arxwt/0 males and found 255 and 171 genes signifi-
cantly up- and down-regulated in Arxdup24/0 mice, respectively
(DEseq2 algorithm, exon reads, P < 0.025 and Supplementary
Material, Table S2). Pathway analysis unraveled major differen-
ces between up- and down-regulated genes (Fig. 5A): while
down-regulated genes were endowed with synaptic
transmission-related functions, up-regulated genes were
mostly related to various aspects of central nervous system de-
velopment and DNA interaction (Fig. 5A). Of note, some of the
previously identified Arx target genes (Lmo1, Lmo3, Lmo4, Shox2,
Gbx2, Lhx7/8, Ebf3, Rasgef1b; (13–15)) were not found significantly
deregulated in Arxdup24/0 E15.5 forebrains.
To relate our results to GABAergic interneuron (IN) develop-
ment for which Arx is known to be important, we took
advantage of three previous experimental datasets (31–33),
which investigated genes specifically expressed (markers) or
silenced in GABAergic INs. We found down-regulated genes
highly enriched in interneuron markers, namely cortical (E13
P < 1.4e–21, E14 P < 7.8e–19, hypergeometric test, Bonferroni
correction) and ganglionic eminence (GE) IN precursors (E14
P < 4.6e–36, hypergeometric test, Bonferroni correction) or ma-
ture IN (P30 P < 4.2e–9, hypergeometric test, Bonferroni correc-
tion) (Fig. 5B). In contrast, up-regulated genes were enriched in
genes normally silenced in IN (E13 P < 8e–87, E14 P < 2.1e–76,
hypergeometric test, Bonferroni correction; Fig. 5B) with enrich-
ment scores consistent amongst the three datasets. Moreover,
we found a strong correlation between the specificity of IN
markers and the degree of enrichment in Arxdup24/0 down-
regulated genes and reciprocally between the specificity of IN si-
lenced genes and the degree of enrichment in Arxdup24/0 up-
regulated genes (Fig. 5C). This suggests that the 24 bp duplica-
tion causes a specific down-regulation of highly specific IN
markers and an up-regulation of genes not meant to be
expressed in INs in normal conditions. To ensure the reliability
of our RNA-seq results, a subset of dysregulated genes were se-
lected and analyzed in E15.5 forebrains of Arxdup24/0 and Arxwt/0
control littermates using real-time quantitative polymerase
chain reaction (RT-qPCR). For all genes analyzed, RT-qPCR
results confirmed the deregulation observed in RNA-seq experi-
ments, although not always with the same magnitude or level
of statistical significance (Fig. 5D).
Delayed interneuron development in Arxdup24/0
forebrains
As our RNA-seq results suggested a perturbation of IN develop-
ment, we thus investigated GABAergic IN populations at E15.5
using different IN markers to examine the number of labeled
positive cells per mm2 in different brain regions. The pattern of
Calbindin (CB) labeling, a general marker of GABAergic INs, was
similar in both localization and structures between Arxdup24/0
and Arxwt/0 males (Fig. 6A and B), however, there was a general
decreased intensity of CB immunolabeling in Arxdup24/0 E15.5
embryos, especially in the thalamus, hypothalamus and amyg-
dala, consistent with the decreased Calb1 expression observed
in RNA-seq experiments at this stage. Although the number of
CBþ cells per mm2 was not changed in the mutant hippocam-
pus, we found a decreased number of CBþ cells in the cortex,
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the striatum and the amygdala of Arxdup24/0 mice (Fig. 6C, D
and G). Similar results were obtained with Calretinin (CR)
immunolabeling (Fig. 6G). Next, we looked at CBþand
CRþdistribution in the different IN migration streams within
the cortex. In the cortex of Arxdup24/0 mice, we found no differ-
ence in the number of CBþor CRþ cells in the marginal zone
(MZ), but we observed a significant decrease in the number of
CBþor CRþ cells in the cortical plate (CP)/subplate (SP), as well
as in the subventricular zone/intermediate zone (SVZ/IZ) of
Arxdup24/0 embryos compared to Arxwt/0 embryos (Fig. 6E and F).
Similar results were also observed with ARXþ cells
(Supplementary Material, Fig. S2G and H). In contrast, we did
not notice any change with somatostatin (SST) immunolabel-
ing, which is consistent with the absence of deregulation of Sst
in the RNA-seq experiments at this stage. Finally, there was a
slight decreased number of Choline acetyltransferase (ChAT)
expressing cells in Arxdup24/0 mice that seemed to be restricted
to the developing striatum and not to the other basal choliner-
gic nuclei (data not shown). We excluded that the decreased
number of interneurons in the different brain regions was due
to interneuron progenitor proliferation defect or increased cell
apoptosis of interneurons as the number of phosphohistone 3
positive (PH3) cells in the ventricular zone of the GE and the
number of cleaved caspase 3 positive cells within the brain
were similar between Arxdup24/0 and Arxwt/0 embryos (PH3: Arxwt/0:
535.2 6 26.4 cells/mm2 n ¼ 4 versus Arxdup24/0: 555.1 6 31.1 cells/
mm2 n ¼ 5, P ¼ 0.6518, Student t-test). Taken together these
results suggest that the 24 bp duplication in Arx gene induces a
defect of IN migration in Arxdup24/0 mice at E15.5, (i) from the GE
to the cortex and to a lesser extent, to the hippocampus and (ii)
from the GE to the subpallial structures including the striatum.
We then investigated glutamatergic neuronal populations at
E15.5 using different projecting neuron markers including
markers of radial glia cells (Pax6), intermediate progenitors
(Tbr2) and post-mitotic neurons (Tbr1) in the cortex. We did not
observe any difference in the number of Pax6þand Tbr2þ cells,
but we observed a small decrease (7.2%) in the number of
Tbr1þ cells between Arxwt/0 and Arxdup24/0 E15.5 cortexes
(Supplementary Material, Fig. S2I). In addition, as Arx loss-of-
function in cortical progenitors has been shown to lead to pro-
liferation defects (2,34,35), we labeled dividing progenitors in
cortical ventricular and subventricular zones with an anti-PH3
antibody. However, the same number of PH3þ cells was ob-
served both in the VZ and SVZ of Arxwt/0 and Arxdup24/0 E15.5 cor-
texes (Supplementary Material, Fig. S2I). Thus the 2 4bp
duplication in Arx gene slightly reduced projecting neuron
number but did not affect proliferation at this stage. We thus
decided to focus on interneuron populations.
At P0 and adult stages, brain structures labeled with ARX, CB,
CR, parvalbumin (PV) or SST appeared similar between Arxdup24/0
and Arxwt/0 mice. Furthermore, the total number of IN expressing
these different markers was comparable between Arxdup24/0 and
Arxwt/0 in the cortex, striatum and hippocampus (data not shown).
However, at P0, we noticed changes in the distribution of ARXþ,
CBþ, CRþand SSTþ cells in both somatosensoriel and motor cor-
texes, analyzed by dividing these cortical regions into 10 bins of
the same size and counting the number of cells in each bin
(Supplementary Material, Fig. S4A–H). We found less cells in cen-
tral parts of the CP (bin 4, corresponding approximately to layer IV)
and more cells in either the deeper part of the cortex (bin 7–10)
and/or in upper parts of the cortex (bin 2–3) of Arxdup24/0 (Fig. 6H),
suggesting that migrating INs accumulate in the upper and deeper



































































































Figure 4. Arxdup24/0 males presented impaired fine motor and proprioceptive abilities. (A) The mouse reaching and grasping (MoRaG) test allows to determine mouse
front paw reaching and grasping abilities as well as which front paw (right or left) they use to perform the test. Arxdup24/0 males had a decreased percentage of accurate
reaching (left panel) and grasping (middle panel) than Arxwt/0 mice. The percentage of lateralized mice was similar between Arxdup24/0 and Arxwt/0 mice (right panel).
(B) Although they took the same time to cross the beam, Arxdup24/0 males displayed increased number of slips in the beam walking test when compared to Arxwt/0
males. (C) Automated gait analysis showed increased duration of the stance for the right hind paw (left panel) due to increased duration of the brake for the left fore-
paw (middle left panel), and of the propel for the left hind paw (middle right panel). Arxdup24/0 males also had an increased step angel for the forelimbs (right panel).
*P <0.05, **P<0.01, ***P<0.001 versus wt.
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into the CP following the tangential migration. In adult, these
defects in cortical IN distribution were still present, but more sub-
tle with ARX and CB markers and absent with CR, PV and SST
markers (Fig. 6I). In the striatum of P0 mice, although there was no
statistical difference between the number of ARXþ, CBþor
CRþ cells, we observed a 22.8% decreased number of ChATþ cells
(Fig. 6J and Supplementary Material, Fig. S4I and J), which




Figure 5. RNA-seq analysis of genes deregulated in Arxdup24/0 E15.5 forebrain revealed interneuron development defects. (A) Gene ontology (GO) enrichments for
deregulated genes. Radar plot in which outer rings correspond to more significant enrichments (Bonferroni corrected P values, Z-score scale). (B) Study of interneuronal
(IN) markers and IN-silenced genes. Histogram of the Bonferroni corrected P values (hypergeometric enrichment) at E13 (32), E14 (31) and P30 (33). Some illustrative
genes are shown on the right. (C) The 24 bp duplication impacts the hallmarks of neuronal identity. In each graph, Marsh’s dataset was used to calculate IN-markers or
IN-silenced genes with increasing specificity and Arxdup24/0 deregulated genes were tested for enrichment against the progressive values of IN specificity. The left graph
shows that the more we selected extremely specific IN markers (genes that are expressed only in IN and completely silenced in all other cell types) the more they were
enriched in Arxdup24/0 down-regulated genes. In other terms, Arxdup24/0 may cause the down-regulation of the specific hallmarks that distinguish IN from other cell
types, such as Gad1 or Npy. The right graph shows the up-regulation of genes that were strongly meant to be silenced in interneurons. (D) Validation by RT-qPCR of
seven genes identified by RNA-seq experiments in Arxdup24/0 and Arxwt/0 E15.5 forebrains. We observed similar changes in the expression level of tested genes, i.e. in-
creased expression of Rnd2 and Wnt5a genes and decreased expression of Foxp1, Tac1, Drd1 and Cacna1a genes although not reaching statistical significance for Rnd2
and Cacna1a (n¼4 for each genotype, Student t-test). As observed in RNA-seq data, the expression of the Pcsk6 gene was not changed in Arxdup24/0 compared to Arxwt/0
E15.5 forebrains.
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Figure 6. Expression and distribution of GABAergic interneuron markers at E15.5, P0 and in adult. (A and B) At E15.5, brain structures labeled with CB were similar be-
tween Arxwt/0 (A) and Arxdup24/0 (B) males. However, there was a strong decrease in the number of CBþ cells in the neocortex (C and D). (E and F) At early stages of corti-
cal development, two streams of migrating IN can be identified in the pallium: one located just above the ventricular/subventricular (VZ/SVZ) surface and another
positioned at the level of the marginal zone (MZ). Between E15.5 and E16.5, a third subplate (SP) stream forms between the SVZ/intermediate zone (IZ) and MZ streams.
We thus looked at the number of CBþ and CRþ neurons in the different streams. (E) We observed a significant decrease in the number of CBþ cells in the subplate (SP)/
cortical plate (CP) and in the subventricular zone (SVZ)/intermediate zone (IZ) of the cortex of Arxdup24/0 compared to Arxwt/0 mice (n¼4 for Arxwt/0, n¼6 for Arxdup24/0,
Student t-test). (F) Similarly, although CR labeling was comparable between Arxwt/0 and Arxdup24/0 males, there was a decreased number of CRþ cells in the SP/CP and in
the SVZ/IZ of the cortex of Arxdup24/0 compared to Arxwt/0 mice (n¼4 for Arxwt/0, n¼5 for Arxdup24/0, Student t-test). (G) Graphs showing the relative number of CBþ and
CRþ cells in the hippocampus, cortex, striatum and amygdala for Arxdup24/0 versus Arxwt/0 males at E15.5 (Student t-test). (H and I) To analyze IN distribution at P0 and
in adult, cortexes were divided into 10 bins of the same size covering the total thickness of the cortex. (H) At P0, bin 1 corresponds approximately to cortical layer I/II,
bins 2 and 3 to layers II–IV, bin 4 to Layer IV, bins 5 and 6 to layer V and bins 7–10 to layer VI and white matter. Although there was no major difference between the
number of positive cells in the cortex of Arxdup24/0 compared to Arxwt/0 animals, the distribution of Arxþ (H left panel), CBþ (H middle panel) and SSTþ (H right panel)
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in adult striatum where we noticed a 27.7% decreased of
ChATþ cells (Fig. 6J and Supplementary Material, Fig. S4K and L).
Altogether, those results support RNA-seq data and show that the
c.428_451dup24 mutation leads to an alteration of GABAergic IN
development during embryonic development. Although this alter-
ation is partially rescued at P0 and in adult, we still observed sub-
tle defects in cortical IN distribution and a specific reduction of
ChATþ cells in the striatum.
Inhibitory/excitatory imbalance at hippocampal to
basolateral amygdala projections in adult Arxdup24/0
males
Part of the developmental modifications observed in IN popula-
tions could explain the contextual fear conditioning alteration
observed in adult Arxdup24/0 animals. We previously demon-
strated that hippocampal inputs to basolateral amygdala (BLA)
neurons controlled the intensity of the conditioned fear re-
sponse (36). To challenge this hypothesis, we tested the synap-
tic response of hippocampal projections to the BLA using
optogenetic stimulation methods combined with electrophysio-
logical detection of GABAergic synaptic currents in BLA neu-
rons. Our aim was to examine if the c.428_451dup24 mutation
could redefine the inhibitory/excitatory (I/E) balance in this
feed-forward neuronal circuit. To achieve this, we performed vi-
ral infection of the Channelrhodopsin-2 (ChR2) in caudal hippo-
campal neurons to allow expression of ChR2 in some BLA
projecting neurons (Fig. 7A and B). We recorded light-evoked
synaptic currents in BLA neurons at two membrane potentials
allowing separating direct excitatory inputs from ChR2 express-
ing cells (at 70 mV) and indirect inhibitory inputs from
recruited local INs which activation will give rise to GABAergic
currents (at 0 mV) (Fig. 7B). The resulting I/E balance theoreti-
cally dictates the capacity of incoming long range inputs in acti-
vating downstream neurons.
Light-evoked excitatory potentials (EPSCs) were first com-
pared by recording neurons at 70 mV, but their amplitude was
not different between Arxdup24/0 and Arxwt/0 mice (Fig. 7D). We
then recorded light-evoked inhibitory potentials at 0 mV, and
observed a strong tendency toward a decrease in their ampli-
tude in Arxdup24/0 animals (Fig. 7D). However, the I/E balance at
hippocampo-BLA afferents was significantly decreased by the
24 bp duplication (Fig. 7C). Thus, our results suggest that early
development modifications in IN populations have functional
consequences in adults, possibly contributing to the changes in
contextual fear responses observed in Arxdup24/0 adult mice.
cells was slightly different at P0 (n¼4 for Arxwt/0, n¼4 for Arxdup24/0, Student t-test). (I) In adult, bin 1 corresponds approximately to cortical layer I, bins 2–4 to layers II
and III, bin 5 to Layer IV, bins 6 and 7 to layer V and bins 8–10 to layer VI and white matter. The distribution of Arxþ (I left panel) and CBþ (I middle panel) cells was
slightly different in adult Arxdup24/0 mice, but not for SSTþ and PVþ cells (I right panel) (n¼3 for Arxwt/0, n¼3 for Arxdup24/0, Student t-test). (J) In the striatum, the
number of ChATþ neurons was decreased in Arxdup24/0 compared to Arxwt/0 mice at P0 (n¼3 for Arxwt/0, n¼4 for Arxdup24/0, Student t-test) (J left panel) and in adult
(n¼6 for Arxwt/0, n¼6 for Arxdup24/0, Student t-test) (J right panel). Ctx: cortex, Str: striatum, GP: globus pallidus, Th: thalamus, Hyp: hypothalamus, Amyg: amygdala, VZ:
ventricular zone, IZ: intermediate zone, CP: cortical plate, MZ: marginal zone, CB: calbindin. Scale bar: 250 mm.
Figure 7. Electrophysiological recordings of hippocampal to basolateral amygdala connections revealed I/E imbalance in Arxdup24/0 mice. (A) Intra hippocampal injec-
tions of ChR2-coding AAVs can be visualized by YFP-expression. (B) Application of short (1 ms duration) flashes of blue light on amygdala-containing acute slices to
test for synaptic transmission at hippocampo-BLA projections. Light-evoked synaptic currents are recorded using whole cell patch clamp recordings of BLA neurons at
appropriate membrane potentials. Light-evoked synaptic currents are shown at two time scales (left panel: 20 ms and right panel: 10 ms). Right panel: Note that a delay
exists between excitatory (black line, 70 mV) and inhibitory currents (grey line, 0 mV), denoting the recruitment of local interneurons by incoming hippocampal fibers
(feed-forward inhibition). (C and D) Amplitudes of light-evoked excitatory and inhibitory currents were measured in Arxwt/0 (black bar) and Arxdup24/0 (white bars) prepa-
rations. (C) I/E ratios are significantly decreased in Arxdup24/0 neurons. (D) Separation of measured light-evoked currents allows to appreciate that the decrease in I/E ra-
tios is mostly due to a decrease of light-evoked inhibitory currents (right panel). n¼3 for Arxwt/0, n¼5 for Arxdup24/0, Student t-test. Numbers of recorded cells are
indicated.
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Arxdup24/0mice reflect phenotypes observed in
c.428_451dup24 ARX patients
In order to determine to what extent the phenotype is similar
between mouse model and human patients, we investigated 33
French patients carrying the ARX 428_451dup24 mutation
(Table 1) thus completing the initial description of 27 patients
previously published (19). First, we observed that 47.6% of the
ARX patients presented with hyperactivity and stereotyped be-
havior (scores above the 50th percentile threshold on the
Nisonger’s scale). Only 14.3% of ARX patients were assessed as
being calm and 42.9% of them were also recorded with conduct
disorder score (not following rules, temper tantrums, fights
with other children) above the 50th percentile threshold on the
Nisonger’s scale. Stereotyped behavior manifested by rocking
body or head back and forth repetitively, hitting or slapping
patient’s own head, neck, hands or other body parts, and re-
peatedly biting self, hard enough to leave tooth marks or break
skin. Adaptive skills of ARX patients were assessed using the
Vineland adaptive behavioral scale and showed a perfectly ade-
quate interpersonal relationships in 56.3% of them despite their
ID [mean global score on Vineland: 41, SD:15, (20–70)]. Only 71%
of ARX patients had some level of anxiety (with a score above
the 50th percentile), however, only 19% of them presented with
severe anxiety (with a score above the 80th percentile on the
Nisonger’s scale). Only 11% of ARX patients had a depressive ep-
isode, a percentage lower than the general population lifetime
prevalence (19–21% in France; 37).
Regarding their learning and memory abilities, their working
memory was in accordance with their general cognitive abilities
(their working memory index was not significantly different
from their total IQ on Wechsler scales).
Neurological and motor examination of ARX patients did not
show any spasticity, nor motor deficit. Fine motor skills were
impaired in all patients with a range of severity; strikingly,
patient’s hand grasping was very specific. ARX patients scored
higher on the balance subtest of the Lincoln-Oseretsky motor
development scale (LOMDS) than IQ- and age-matched Down
syndrome (DS) patients (t ¼ 3.5, P ¼ 0.003, Student t-test).
Moreover, a writing speed test showed that they were signifi-
cantly more impaired than DS patients (age- and IQ-matched)
with 25 letters copied on average for ARX patients and 40 letters
copied for DS patients (t ¼ 2.1, P < 0.05, Student t-test).
Epilepsy manifestations were observed in 11 of the 33 ARX
c.428_451dup24 patients. Three out of the 33 ARX c.428_451dup24
patients (9.1%) presented with West syndrome [i.e. infantile
spasms, psychomotor regression and hypsarythmia on the elec-
troencephalography (EEG)] with a mean age onset of 5 months,
[4–7]. The other eight patients showed various types of seizures
including absence, complex partial seizures and generalized
tonic-clonic seizures with a mean age onset of 10.1 years, [1.8–
33]. Only three patients required multiple antiepileptic treat-
ment. It was possible after a few years to stop the antiepileptic
treatment in five patients.
Discussion
We describe here the characterization of a new mouse model
partially humanized for the ARX c.428_451dup24 duplication,
leading to polyalanine expansion in ARX tract 2. Our mouse
Table 1. Comparison of phenotypes/clinical features observed in the partially humanized Arx dup24 mouse model and in human ARX
c.428_451dup24 patients
Arxdup24/0 mice ARX c.428_451dup24 patients
Activity & behavior
Hyperactivity in new environment (open field, Y-maze and social
recognition test)
Hyperactivity in 47.6% of ARX patients (Nisonger’s scale). Only
14.3% were assessed as being calm.
Normal anxiety level in the elevated plus maze and the open field Only 19% of ARX patients have severe anxiety (>80th percentile,
Nisonger’s scale)
Increased rearing in the circadian activity & the open field, sugges-
tive of stereotypy
Stereotypic behavior in 47.6% of ARX patients (Nisonger’s scale)
Normal despair level in the tail suspension test Depressive episode in only 11% of ARX patients (less frequent than
in control population)
Normal social interaction Despite their ID, 56.3% of ARX patients have perfectly adequate in-
terpersonal relationship (Vineland adaptive behavioral scale)
Learning & memory
Mean IQ: 48, SD: 7, [40–70] (Wechsler scale)
Alteration of contextual fear memory
Normal working memory in the Y-maze Working memory index not significantly different from IQ
(Wechsler scales).
Fine motor & proprioceptive abilities
Defect in reaching in the MoRagTest Impaired reaching component on a kinematic study of a grasping
movement
Defect in grasping in the MoRagTest Impaired grasping component on a kinematic study of a grasping
movement
Increased performance on the rotarod, suggestive of improved mo-
tor coordination
Higher scores on the balance subtest of the LOMDS than IQ- and
age-matched Down syndrome patients.
Normal muscle strength in the grip test Normal muscle strength on motor examination.
Epilepsy
Infantile spasms in 8% of Arxdup24/0 pups 9.1% of ARX patients presented with West syndrome (mean age
onset: 5 months, [4–7])
IQ, intelligence quotient.
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model supports previous findings showing that this mutation
causes a decreased expression of Arx (23,27,38). It has been
shown that polyalanine expansions cause inappropriate oligo-
merization of the protein, which is targeted for clearance by the
cellular quality-control machinery (24,39), thus possibly
explaining the decreased amount of ARX protein that we ob-
served both in western blot (Fig. 1E) and by immunohistochem-
istry (Supplementary Material, Fig. S2). However, this does not
explain 12% decreased amount of mRNA that we observed
both at E15.5 and adult stage. Interestingly, we found that the
24 bp duplication leads to DNA instability of the polyalanine
tract 2 (see Supplementary Material, Fig. S1), with the recurrent
apparition of products of smaller and larger size but always in
frame, suggesting that they are not the result of a technical bias
due to PCR amplification. Unfortunately, we were not able to de-
tect the corresponding proteins by western blot, either due to a
lack of sensitivity of the antibody (as the amount of these prod-
ucts is very low compared to the 24 bp duplication mutated pro-
tein) or because these mRNAs may be unstable and thus
degraded. This last hypothesis would give a possible explana-
tion for the decreased amount of Arx mRNA observed.
Alternatively, it could also be a direct consequence of the pres-
ence of 24 bp duplication that would make the mRNA less sta-
ble. Interestingly, this instability was also found in ARX
c.428_451dup24 patient DNA extracted from blood cells, suggest-
ing that the same situation also occurs in human.
The behavioral defects observed in the partially humanized
Arxdup24/0 mouse model are strikingly similar to the symptoms
observed in ARX c.428_451dup24 patients (Table 1), as far as hu-
man/mouse neurobehavioral phenotypes can be compared.
ARX patients have initially been described with a strong pheno-
typic heterogeneity. However, a recent clinical re-evaluation of
27 patients from 12 different families, confirmed by the present
description of 6 additional patients, all evaluated by the same
clinician, revealed that this mutation constitutes a recognizable
clinical syndrome with ID, an oro-lingual apraxia and a very
specific upper limb distal motor apraxia with a very specific
hand grasping but a normal gross motor function (19; this
study). We observed good correspondence between Arxdup24/0
mice and ARX patients concerning hyperactivity and stereotypy
manifestations. Strikingly, the percentage of Arxdup24/0 P7-P11
pups presenting infantile spasms (8%) was very similar to the
9.1% of ARX patients presenting with West syndrome (Table 1).
However, we remarked differences concerning the manifesta-
tion of anxiety (most ARX patients had some level of anxiety
whose only a minority had severe anxiety, whereas Arxdup24/0
mice had similar level of anxiety than Arxwt/0 mice, although
the presence of hyperactivity and stereotypy in new environ-
ments may reveal some level of anxiety). No change was noted
in working or spatial memory, but we observed alteration in
contextual memory for fear in mice. The hyperactivity and the
alteration in associative memory in Arxdup24/0 mice are very sim-
ilar to the phenotypes described for Dlx1/mutant mice (40,41),
and thus consistent with a defect in interneuron development.
Similarly to ARX patients, Arxdup24/0 mutant mice have good per-
formance in the gross motor coordination as revealed in the
rotarod test, whereas they presented with fine motor defects in
the MoRaG test, automated gait analysis and the beam walking
test, more suggestive of an alteration of gait and proprioceptive
and fine motor abilities. It is interesting to note that motor
defects were more easily detected in mutant mice than defects
in learning and memory abilities. This is possibly due to the bet-
ter sensitivity of mouse tests assessing locomotor functions
than neuropsychological tests which would allow only the
detection of severe phenotypes in mice. Moreover, ARX
c.428_451dup24 patients are considered to have mild ID, thus, al-
though we detected an associative memory phenotype in mice,
the cognitive phenotypes could be too mild to be significantly
detected using the current battery of tests.
Previously, two mouse models for the expansion in the poly-
alanine tract 1 [c.304ins(GCG)7] have been described (22,23).
These mouse models displayed infantile motor spasms, severe
seizures, distinctive EEG abnormalities and cognitive and be-
havioral abnormalities, such as impaired associative learning,
abnormal social interaction and contradictory results concern-
ing anxiety (22,23). Interestingly, our mouse model presents
similarities with these Arx c.304ins(GCG)7 mouse models, in par-
ticular concerning the infantile spams and the alteration in as-
sociative learning. However, it shows several differences,
suggestive of a milder phenotype, with a smaller proportion of
animals presenting infantile spontaneous motor spasms [5 af-
fected over 15 pups for the Arx c.304ins(GCG)7 mouse model and
only 2 affected over 25 pups for our Arx c.428_451dup24 mouse
model], the absence of increased susceptibility to induced epi-
lepsy for Arx c.428_451dup24 mouse model and the fear condi-
tioning test for which Arx c.304ins(GCG)7 mice present alteration
in both the cue and the contextual memories (22,23) whereas
Arx c.428_451dup24 mouse model is only affected for contextual
memory. Those results are in agreement with what has been
reported for human patients presenting ARX c.428_451dup24
mutations who are described as less severely affected than
patients with ARX c.304ins(GCG)7 expansion (28,42,43). Another
mouse model for ARX c.428_451dup24 mutation has been re-
cently described with much more pronounced spontaneous
seizures activity than our model (38). This difference may be
due to a different environmental condition affecting the ani-
mals. This model was generated by Kitamura et al. (23) on 129SV
ES cells and then bred on C57BL/6J (B6J) and backcrossed on
C57BL/6NHsd (B6NHsd) genetic background in Jackson’s publi-
cation (38). The only difference with our model is that the latter
was backcrossed on B6NTac genetic background. Thus, we may
propose that the B6NHsd are more prone to seizures than the
B6NTac. Indeed, differences in epilepsy and death susceptibility
after pro-convulsant injection have been reported between dif-
ferent B6N strains (44). However, it is interesting to note that
originally, when Kitamura et al. (23) first published this mouse
model, they did not observe any particular phenotype including
epilepsy. In addition, the phenotype we observed in our mouse
model is much closer to the rather mild phenotype observed in
the patients, especially concerning the frequency and severity
of infantile spasms and epilepsy. The most striking features of
our mouse model is that it also recapitulates the fine motor
defects which is a common hallmark of ARX c.428_451dup24
patients (19).
Comparison of our RNA-seq results performed on E15.5
Arxdup24/0 and Arxwt/0 forebrains with published databases
revealed a global decreased expression of genes important for
interneuron development and/or migration (Fig. 3). Accordingly,
we found defects in interneuron subpopulations, especially in
the number and distribution of CBþ, CRþand ChATþ cells at
E15.5. At P0, we showed an accumulation of IN in the periphery
of the CP and a decreased proportion in the center of the CP.
This observation may be caused by IN being delayed to pene-
trate cortical layers by radial migration (as previously suggested
for Arx knockout mice; (2)). A defect in neuronal migration is
further strengthened by the enrichment of genes involved in
cell migration among deregulated genes in E15.5 Arxdup24/0 mice
( P ¼ 4.11  1011, ingenuity pathway analysis). Eventually, the
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IN distribution defects in our mouse model were partially com-
pensated at adult stage, although the distribution of some inter-
neuron subpopulations was still impaired in adult cortex.
Interestingly, interneuron subpopulations affected in Arxdup24/0
mutant mice were very similar to the ones affected in Arx
mouse models for other mutations (2,9,13,22,23,45,46). Finally, it
is interesting to draw a parallel between IN alterations in the
striatum and the cortex (including the motor cortex) and the
fine motor alterations. It has been shown that the cortical to
basal ganglia (which include the striatum) interconnections
play key function in motor learning and in coordinated volun-
tary motor movements (47). Strikingly, we found a decrease in
the volume of some basal ganglia nuclei (in particular the cau-
date nucleus) in ARX c.428_451dup24 patients, and we noted a
correlation between the volume reduction and patients’ motor
impairment severity (Curie, Friocourt et al., submitted), reinforc-
ing the importance of subpallial development in the peculiar
fine motor defects observed in these patients.
Phospho-H3 labeling in the GE did not show any significant
difference of the number of dividing progenitors in Arxdup24/0
mice compared to Arxwt/0 mice. However, when comparing our
RNA-seq dataset with a recently published one on medial gan-
glionic eminence (MGE)-derived cellular populations at different
embryonic stages (48), we observed a global increased expres-
sion of genes normally expressed in MGE proliferating neural
progenitors (such as Cenpf, Ccnb2, Ccnb1, Mcm5, Lhx5, Hes1,
Notch1, Notch2, Nde1, Cdca3, Cdca8 and Psat1) and a tendency of
decreased expression of genes normally expressed in MGE post-
mitotic immature neurons (such as Nrxn3, Celf5, Gad1, Stmn2,
Stmn3, Celf5, Dnm3 and Cxx1c) in Arxdup24/0 E15.5 embryos, sug-
gesting a global delay in the generation/maturation of MGE neu-
rons that may be compensated at later stages. The MGE
produces cortical INs, but also contributes to the generation of
striatal interneurons and cholinergic neurons and pallial projec-
tion neurons (49,50). This defect may also concern the lateral
ganglionic eminence (LGE) (responsible for the production of
majority of striatal neurons) and caudal ganglionic eminence
(CGE) (responsible for the production of neurons of cortex,
amygdala and hippocampus) but it is difficult to tell just from
RNA-seq results, as these three structures lack specific gene sig-
nature (51,52). Thereby, an alteration of the generation/matura-
tion of the MGE, LGE and CGE neurons would explain the
decreased number of different neuron types, namely CBþ,
CRþand ChATþ cells observed in the cortex and subpallial
structures at E15.5, and the decreased expression of genes im-
portant for striatal neuron development such as Foxp1, Drd1 and
Tac1 (Fig. 3D). Further analysis using different protein markers
or in situ hybridization probes will be necessary to fully charac-
terize this maturation delay. Finally, as impaired interneuron
function was also suggested by epilepsy manifestations both in
Arxdup24/0 pups and ARX c.428_451dup24 patients, we thus inves-
tigated the consequences of a defect in interneuron migration
and/or development at adult stage by analyzing electrophysio-
logical properties at hippocampal to BLA connections. We
detected an alteration of I/E balance, which is interesting to cor-
relate with the alteration observed in the contextual fear condi-
tioning as efficient hippocampal projections to the BLA have
been shown to be crucial for the aversive conditioned response
in mice (36).
Arx was shown to be also important for excitatory neuron
development (34,35,53,54), thus we also looked at markers of py-
ramidal neurons. The slight decreased in the number of
Tbr1þ cells observed at E15.5 suggests that the global delay of
neuronal generation/maturation suspected in GE may also be
present in this neuronal population. However, we did not detect
any change in the expression or localization of Pax6 or
Tbr2þ cells in the cortex. Further studies would be required to
fully investigate this aspect. However, the absence of increased
susceptibility to induced epilepsy in Arxdup24/0 adult males is not
in favor of major defects in pyramidal neurons.
In conclusion, our new mouse model expressing the human
ARX c.428_451dup24 mutation appears as a relevant model to
further dissect the pathophysiological effects of this mutation
and for the development of therapeutic approaches, as it shows
striking similarities with human patients, especially in behavior
with hyperactivity and defects in fine motor and proprioceptive
abilities. It highlights alteration of generation, migration and
functioning of interneurons in various regions of the brain as a
direct consequence of 24 bp duplication effect on Arx function.
Even if most of adult interneurons recover their position, the
rescue is not complete, inducing a series of changes in the over-
all activity, a defect in associative learning and in controlling
fine motor movements.
Materials and Methods
Mouse line and ethical statement
The ArxKI.ICS mutant mouse line (noted Arxdup24/0) was generated
and analyzed in the mouse genetic background C57BL/6N*129Sv/
Pas*C57BL/6J (95.3*3.1*1.5%, Supplementary Material, Fig. 1A
and B). All mouse experimental procedures were performed in
agreement with the EC directive 2010/63/UE86/609/CEE for the
care and use of laboratory animals and every effort was made to
minimize the number of animals used and their suffering. The
behavioral pipeline was approved by the local animal care, use
and ethic committee of the Institute of Genetics and of Molecular
and Cellular Biology (IGBMC) under accreditation number 2012-
139. The experimental design and procedures of electrophysio-
logical experiments were performed in accordance with the ani-
mal care guidelines issued by the animal experimental
committee of Bordeaux Universities (CE50, A5012009).
Behavioral experiments
Five cohorts of Arxwt/0 and Arxdup24/0 male mice were used for
behavioral experiments (8–15 per genotype and per cohort) and
9–31 weeks old mice were tested for circadian activity, general
health, basic neurological reflexes, anxiety related behavior,
susceptibility to despair, learning and memory (emotional, spa-
tial), working memory, social recognition, proprioceptive abili-
ties, specific motor abilities, gait analysis and susceptibility to
epileptic seizures. One cohort of P7–P11 pups (25 mutants and
34 controls males) were investigated for spontaneous infantile
spasms. The behavioral tests and cohorts used are described in
the Supplementary Material.
Electrophysiology
All electrophysiological experiments were performed on
2 months old males (five Arxdup24/0 and three Arxwt/0 littermates).
Mice were injected in the caudal hippocampus with adeno-
associated viruses (AAV) containing the channel rhodopsin
gene ChR2. After waiting 4 weeks for ChR2 gene expression, we
prepared coronal BLA-containing acute slices from infected
mice and recorded neurons visualized with infrared video mi-
croscopy in the voltage clamp mode at 70 mV [to record
AMPAR-mediated excitatory postsynaptic currents (EPSCs)]
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or 0 mV (to record GABAAR-mediated inhibitory postsynaptic
currents) (36). Hippocampo-BLA monosynaptic EPSCs and di-
synaptic inhibitory postsynaptic currents were elicited by 1 ms
light-stimulations. Details of the electrophysiological proce-
dures used are described in the Supplementary Material.
RNA-seq libraries and analysis
Total RNA was Trizol-extracted from three wild-type and three
mutant frozen embryonic forebrains (including developing cor-
tex and basal ganglia). All steps of RNA treatment and cDNA
preparation are described in the Supplementary Material. The
RNA-seq libraries were synthetized with KAPA Hyper prep kit
and sequenced on Illumina HiSeq and mapped with GSNAP
(version 2015–06-23), which yielded on average 51.1 mapped
million (single-end) reads per sample. Gene expression counts
(tags only in exons, not introns) were given as input to DEseq2
to call the dysregulated genes. Data were deposited in GEO (ID
GSE90036). RNA-seq results were compared with the published
datasets (31–33) by means of hypergeometric test with
Bonferroni correction. Specifically, (i) we estimated the back-
ground genes by selecting the common annotations between
the RNA-seq dataset (RefSeq annotations) and each microarray
of the published datasets; (ii) we obtained the lists of deregu-
lated genes in the published datasets by selecting the genes
with fold-change superior to two according to the values avail-
able in the Supplementary Materials and (iii) we computed hy-
pergeometric test with Bonferroni correction.
Immunohistochemistry on brain sections and cell
counting
Brains from 13-week-old, post-natal day 0 (P0) and day-post-
coı̈tum 15.5 (E15.5) Arxdup24/0 and Arxwt/0 males (4–6 of each ge-
notype) were harvested as described elsewhere (55). Antibodies
and immunohistochemistry procedures are described in the
Supplementary Material.
ARX c.428_451dup24 patients
After explaining the aims of the study, all patients and their
guardians gave written informed consent for the study, which
was approved by the Ethical Committee of French Public
Hospitals (Comité de Protection des Personnes Lyon-Sud Est II,
2010-A00327–32, 09/22/2010).
Supplementary Material
Supplementary Material is available at HMG online.
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Lejeune Foundation (2007–2014 to G.F.), IBSAM (2016–2017 to G.F.);
Gaétan Saleün Association (to G.F.). The funders had no role in
the study design, data collection and analysis, decision to publish
or manuscript preparation. Funding to pay the Open Access pub-
lication charges for this article was provided by Y.H.
References
1. Dobyns, W.B., Truwit, C.L., Ross, M.E., Matsumoto, N., Pilz,
D.T., Ledbetter, D.H., Gleeson, J.G., Walsh, C.A. and
Barkovich, A.J. (1999) Differences in the gyral pattern distin-
guish chromosome 17-linked and X-linked lissencephaly.
Neurology, 53, 270–277.
2. Kitamura, K., Yanazawa, M., Sugiyama, N., Miura, H., Iizuka-
Kogo, A., Kusaka, M., Omichi, K., Suzuki, R., Kato-Fukui, Y.
and Kamiirisa, K. (2002) Mutation of ARX causes abnormal
development of forebrain and testes in mice and X-linked
lissencephaly with abnormal genitalia in humans. Nat.
Genet., 32, 359–369.
3. Bonneau, D., Toutain, A., Laquerriere, A., Marret, S., Saugier-
Veber, P., Barthez, M.A., Radi, S., Biran-Mucignat, V.,
Rodriguez, D. and Gelot, A. (2002) X-linked lissencephaly
with absent corpus callosum and ambiguous genitalia
(XLAG): clinical, magnetic resonance imaging, and neuro-
pathological findings. Ann. Neurol., 51, 340–349.
4. Kato, M., Das, S., Petras, K., Kitamura, K., Morohashi, K.,
Abuelo, D.N., Barr, M., Bonneau, D., Brady, A.F., Carpenter,
N.J. et al. (2004) Mutations of ARX are associated with striking
pleiotropy and consistent genotype-phenotype correlation.
Hum. Mutat., 23, 147–159.
5. Friocourt, G., Poirier, K., Rakic, S., Parnavelas, J.G. and Chelly,
J. (2006) The role of ARX in cortical development. Eur. J.
Neurosci., 23, 869–876.
6. Friocourt, G. and Parnavelas, J.G. (2010) Mutations in ARX re-
sult in several defects involving GABAergic neurons. Front.
Cell Neurosci., 4, 4.
7. Shoubridge, C., Fullston, T. and Gecz, J. (2010) ARX spectrum
disorders: making inroads into the molecular pathology.
Hum. Mutat., 31, 889–900.
8. Poirier, K., Van Esch, H., Friocourt, G., Saillour, Y., Bahi, N.,
Backer, S., Souil, E., Castelnau-Ptakhine, L., Beldjord, C.,
Francis, F. et al. (2004) Neuroanatomical distribution of ARX
in brain and its localisation in GABAergic neurons. Brain Res.
Mol. Brain Res., 122, 35–46.
9. Colombo, E., Collombat, P., Colasante, G., Bianchi, M., Long, J.,
Mansouri, A., Rubenstein, J.L. and Broccoli, V. (2007)
Inactivation of Arx, the murine ortholog of the X-linked lissen-
cephaly with ambiguous genitalia gene, leads to severe disorga-
nization of the ventral telencephalon with impaired neuronal
migration and differentiation. J. Neurosci., 27, 4786–4798.
10. Colasante, G., Collombat, P., Raimondi, V., Bonanomi, D.,
Ferrai, C., Maira, M., Yoshikawa, K., Mansouri, A., Valtorta, F.,
Rubenstein, J.L. et al. (2008) Arx is a direct target of Dlx2 and
thereby contributes to the tangential migration of
GABAergic interneurons. J. Neurosci., 28, 10674–10686.











egen user on 03 June 2021
11. Cobos, I., Broccoli, V. and Rubenstein, J.L. (2005) The verte-
brate ortholog of aristaless is regulated by Dlx genes in the
developing forebrain. J. Comp. Neurol., 483, 292–303.
12. Stuhmer, T., Anderson, S.A., Ekker, M. and Rubenstein, J.L.
(2002) Ectopic expression of the Dlx genes induces glutamic
acid decarboxylase and Dlx expression. Development, 129,
245–252.
13. Fulp, C.T., Cho, G., Marsh, E.D., Nasrallah, I.M., Labosky, P.A.
and Golden, J.A. (2008) Identification of Arx transcriptional
targets in the developing basal forebrain. Hum. Mol. Genet.,
17, 3740–3760.
14. Quille, M.L., Carat, S., Quemener-Redon, S., Hirchaud, E.,
Baron, D., Benech, C., Guihot, J., Placet, M., Mignen, O., Ferec,
C. et al. (2011) High-throughput analysis of promoter occu-
pancy reveals new targets for Arx, a gene mutated in mental
retardation and interneuronopathies. PLoS One, 6, e25181.
15. Colasante, G., Sessa, A., Crispi, S., Calogero, R., Mansouri, A.,
Collombat, P. and Broccoli, V. (2009) Arx acts as a regional
key selector gene in the ventral telencephalon mainly
through its transcriptional repression activity. Dev. Biol., 334,
59–71.
16. Friocourt, G. and Parnavelas, J.G. (2011) Identification of Arx
targets unveils new candidates for controlling cortical inter-
neuron migration and differentiation. Front. Cell Neurosci., 5,
28.
17. McKenzie, O., Ponte, I., Mangelsdorf, M., Finnis, M.,
Colasante, G., Shoubridge, C., Stifani, S., Gecz, J. and Broccoli,
V. (2007) Aristaless-related homeobox gene, the gene re-
sponsible for West syndrome and related disorders, is a
Groucho/transducin-like enhancer of split dependent tran-
scriptional repressor. Neuroscience, 146, 236–247.
18. Gecz, J., Cloosterman, D. and Partington, M. (2006) ARX: a
gene for all seasons. Curr. Opin. Genet. Dev., 16, 308–316.
19. Curie, A., Nazir, T., Brun, A., Paulignan, Y., Reboul, A.,
Delange, K., Cheylus, A., Bertrand, S., Rochefort, F., Bussy, G.
et al. (2014) The c.429_452 duplication of the ARX gene: a
unique developmental-model of limb kinetic apraxia.
Orphanet. J. Rare Dis., 9, 25.
20. Nasrallah, I.M., Minarcik, J.C. and Golden, J.A. (2004) A polya-
lanine tract expansion in Arx forms intranuclear inclusions
and results in increased cell death. J. Cell Biol., 167, 411–416.
21. Shoubridge, C., Cloosterman, D., Parkinson-Lawerence, E.,
Brooks, D. and Gecz, J. (2007) Molecular pathology of ex-
panded polyalanine tract mutations in the aristaless-related
homeobox gene. Genomics, 90, 59–71.
22. Price, M.G., Yoo, J.W., Burgess, D.L., Deng, F., Hrachovy, R.A.,
Frost, J.D., Jr and Noebels, J.L. (2009) A triplet repeat expan-
sion genetic mouse model of infantile spasms syndrome,
Arx(GCG)10þ 7, with interneuronopathy, spasms in infancy,
persistent seizures, and adult cognitive and behavioral im-
pairment. J. Neurosci., 29, 8752–8763.
23. Kitamura, K., Itou, Y., Yanazawa, M., Ohsawa, M., Suzuki-
Migishima, R., Umeki, Y., Hohjoh, H., Yanagawa, Y., Shinba,
T., Itoh, M. et al. (2009) Three human ARX mutations cause
the lissencephaly-like and mental retardation with
epilepsy-like pleiotropic phenotypes in mice. Hum. Mol.
Genet., 18, 3708–3724.
24. Polling, S., Ormsby, A.R., Wood, R.J., Lee, K., Shoubridge, C.,
Hughes, J.N., Thomas, P.Q., Griffin, M.D., Hill, A.F., Bowden,
Q. et al. (2015) Polyalanine expansions drive a shift into
alpha-helical clusters without amyloid-fibril formation. Nat.
Struct. Mol. Biol., 22, 1008–1015.
25. Seufert, D.W., Prescott, N.L. and El-Hodiri, H.M. (2005)
Xenopus aristaless-related homeobox (xARX) gene product
functions as both a transcriptional activator and repressor
in forebrain development. Dev. Dyn., 232, 313–324.
26. Nasrallah, M.P., Cho, G., Simonet, J.C., Putt, M.E., Kitamura,
K. and Golden, J.A. (2012) Differential effects of a polyalanine
tract expansion in Arx on neural development and gene ex-
pression. Hum. Mol. Genet., 21, 1090–1098.
27. Lee, K., Mattiske, T., Kitamura, K., Gecz, J. and Shoubridge, C.
(2014) Reduced polyalanine-expanded Arx mutant protein in
developing mouse subpallium alters Lmo1 transcriptional
regulation. Hum. Mol. Genet., 23, 1084–1094.
28. Stromme, P., Mangelsdorf, M.E., Shaw, M.A., Lower, K.M.,
Lewis, S.M., Bruyere, H., Lutcherath, V., Gedeon, A.K.,
Wallace, R.H., Scheffer, I.E. et al. (2002) Mutations in the hu-
man ortholog of aristaless cause X-linked mental retarda-
tion and epilepsy. Nat. Genet., 30, 441–445.
29. Collins, R.L. (1968) On the inheritance of handedness. I.
Laterality in inbred mice. J. Hered., 59, 9–12.
30. Collins, R.L. (1969) On the inheritance of handedness. II.
Selection for Sinistrality in Mice. J. Hered., 60, 117–119.
31. Marsh, E.D., Minarcik, J., Campbell, K., Brooks-Kayal, A.R.
and Golden, J.A. (2008) FACS-array gene expression analysis
during early development of mouse telencephalic interneur-
ons. Dev. Neurobiol., 68, 434–445.
32. Batista-Brito, R., Machold, R., Klein, C. and Fishell, G. (2008)
Gene expression in cortical interneuron precursors is pre-
scient of their mature function. Cereb. Cortex, 18, 2306–2317.
33. Zeisel, A., Munoz-Manchado, A.B., Codeluppi, S.,
Lonnerberg, P., La Manno, G., Jureus, A., Marques, S.,
Munguba, H., He, L., Betsholtz, C. et al. (2015) Cell types in the
mouse cortex and hippocampus revealed by single-cell
RNA-seq. Science, 347, 1138–1142.
34. Friocourt, G., Kanatani, S., Tabata, H., Yozu, M., Takahashi,
T., Antypa, M., Raguenes, O., Chelly, J., Ferec, C., Nakajima, K.
et al. (2008) Cell-autonomous roles of ARX in cell prolifera-
tion and neuronal migration during corticogenesis.
J. Neurosci., 28, 5794–5805.
35. Colasante, G., Simonet, J.C., Calogero, R., Crispi, S., Sessa, A.,
Cho, G., Golden, J.A. and Broccoli, V. (2015) ARX regulates
cortical intermediate progenitor cell expansion and upper
layer neuron formation through repression of Cdkn1c. Cereb.
Cortex, 25, 322–335.
36. Zhang, C.L., Houbaert, X., Lepleux, M., Deshors, M.,
Normand, E., Gambino, F., Herzog, E. and Humeau, Y. (2015)
The hippocampo-amygdala control of contextual fear ex-
pression is affected in a model of intellectual disability. Brain
Struct. Funct., 220, 3673–3682.
37. Kessler, R.C. and Bromet, E.J. (2013) The epidemiology of de-
pression across cultures. Annu. Rev. Public Health, 34,
119–138.
38. Jackson, M.R., Lee, K., Mattiske, T., Jaehne, E.J., Ozturk, E.,
Baune, B.T., O’Brien, T.J., Jones, N. and Shoubridge, C. (2017)
Extensive phenotyping of two ARX polyalanine expansion
mutation mouse models that span clinical spectrum of in-
tellectual disability and epilepsy. Neurobiol. Dis., 105,
245–256.
39. Messaed, C. and Rouleau, G.A. (2009) Molecular mechanisms
underlying polyalanine diseases. Neurobiol. Dis., 34, 397–405.
40. Mao, R., Page, D.T., Merzlyak, I., Kim, C., Tecott, L.H., Janak,
P.H., Rubenstein, J.L. and Sur, M. (2009) Reduced conditioned
fear response in mice that lack Dlx1 and show
subtype-specific loss of interneurons. J. Neurodev. Disord., 1,
224–236.
41. Cobos, I., Calcagnotto, M.E., Vilaythong, A.J., Thwin, M.T.,
Noebels, J.L., Baraban, S.C. and Rubenstein, J.L. (2005) Mice











egen user on 03 June 2021
lacking Dlx1 show subtype-specific loss of interneurons, re-
duced inhibition and epilepsy. Nat. Neurosci., 8, 1059–1068.
42. Stromme, P., Mangelsdorf, M.E., Scheffer, I.E. and Gecz, J.
(2002) Infantile spasms, dystonia, and other X-linked pheno-
types caused by mutations in aristaless related homeobox
gene, ARX. Brain Dev., 24, 266–268.
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